Streetbeat News

Price Targets

UPST

Stephens & Co. analyst Vincent Caintic has reiterated an Underweight rating on Upstart Holdings (NASDAQ:UPST) and maintained a $6 price target.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 12:55 pm

CASY

Stephens & Co. analyst Ben Bienvenu has reiterated an Overweight rating on Casey's General Stores (NASDAQ:CASY) and maintained a price target of $280.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 12:54 pm

WBA

JP Morgan analyst Lisa Gill has maintained a Neutral rating on Walgreens Boots Alliance (NASDAQ:WBA) and lowered the price target from $40 to $35.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 12:53 pm

NKE

JP Morgan analyst Matthew Korn maintains an Overweight rating on Nike (NYSE:NKE) but has lowered the price target from $152 to $146.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 12:52 pm

NVRO

JP Morgan analyst Robbie Marcus has maintained a Neutral rating on Nevro (NYSE:NVRO) and lowered the price target from $40 to $28.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 12:51 pm

WBA

Barclays analyst Steve Valiquette has maintained an Equal-Weight rating on Walgreens Boots Alliance (NASDAQ:WBA) and lowered the price target from $38 to $32.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:46 pm

SNX

Barclays analyst Tim Long has maintained an Equal-Weight rating on TD Synnex (NYSE:SNX) but lowered the price target from $103 to $98.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:44 pm

REGN

Barclays analyst Carter Gould has maintained an Overweight rating on Regeneron Pharmaceuticals (NASDAQ:REGN) but lowered the price target from $915 to $888.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:43 pm

RETA

Barclays analyst Carter Gould maintains an Overweight rating on Reata Pharmaceuticals (NASDAQ:RETA) and raises the price target from $98 to $110.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:42 pm

PLD

Barclays analyst Anthony Powell maintains an Overweight rating on Prologis (NYSE:PLD) but lowers the price target from $160 to $159.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:41 pm